Form 4: BioAffinity Technologies Director Peter Knight Acquires Shares
SEC Form 4 Filing
Director Peter Knight acquired 8,296 shares of BioAffinity Technologies common stock on June 12, 2024, through a grant of restricted shares that vest immediately.
Summary
- On June 12, 2024, Peter Knight, a director of bioAffinity Technologies, Inc., acquired 8,296 shares of common stock.
- The acquisition was a grant of restricted shares that vest immediately.
- The price per share was $0.00.
- Following the transaction, Knight directly owns 83,671 shares of bioAffinity Technologies, Inc.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing, so the sentiment is neutral. The director's acquisition could be seen as a slightly positive signal.
Positives
- The director's acquisition of shares could be seen as a positive signal, indicating confidence in the company's future prospects.
Industry Context
Form 4 filings are standard practice and provide transparency into the transactions of company insiders.
Key Dates
| Date | Description |
|---|---|
| 06/12/2024 | Date of transaction: Peter Knight acquired 8,296 shares of bioAffinity Technologies common stock. |
| 06/14/2024 | Date of signature on the Form 4 filing. |
Keywords
Form 4, Beneficial Ownership, bioAffinity Technologies, BIAF, Peter Knight, Director, Stock Acquisition, Restricted Shares
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.